Clinical Trials Directory

Trials / Recruiting

RecruitingNCT00682513

Studies of the Variable Phenotypic Presentations of Rapid-Onset Dystonia Parkinsonism and Other Movement Disorders

Clinical, Genetic, and Cellular Consequences of Mutations in the NA,K-ATPase ATP1A3

Status
Recruiting
Phase
Study type
Observational
Enrollment
198 (estimated)
Sponsor
State University of New York at Buffalo · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The purposes of this study are to identify persons with rapid-onset dystonia-parkinsonism (RDP) or mutations of the RDP gene, document prevalence of the disease, and map its natural history.

Detailed description

Rapid-onset dystonia-parkinsonism (RDP) is a rare, movement disorder with variable characteristics ranging from sudden onset (hours to days) of severe dystonic spasms to gradual onset of writer's cramp. RDP has elements of both dystonia and Parkinson's disease-two neurological diseases with motor and neuropsychological symptoms that hinder the quality of life. An internal trigger associated with extreme physiological stress has been reported prior to abrupt symptom onset of RDP. This study, which is a continuation of an earlier study begun by Dr. Allison Brashear, aims to more clearly identify the characteristics associated with RDP and to explore whether mutations in the RDP gene are associated with atypical dystonias, Parkinson's disease, and other movement disorders. The study involves in-person or remote (telemedicine) neurological assessments and blood samples for genetic analysis.

Conditions

Timeline

Start date
2008-04-01
Primary completion
2027-07-31
Completion
2027-07-31
First posted
2008-05-22
Last updated
2025-05-01

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00682513. Inclusion in this directory is not an endorsement.